NeoStem, Inc. (Nasdaq: NBS) announced that it has entered into a definitive agreement to acquire California Stem Cell, Inc. ("CSC") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE